Publications Update # 111
In praise of bullshit, ADC list and the payloads discussion, New ESTRO-ESGO-ESP 2025 endometrial guidelines, role of stents during radical hysterectomy and RAMP-201 study summary.
Publications Update
Special July/August Edition
New Academic Year
Long-term readers of this newsletter know I
Publications Update # 110
"When Death Came to Visit," a poem by Andrea Gibson, BRCA and STIC pathology, Diverting loop ileostomy in ovarian cancer, endometrial cancer conversion rates for robotic surgery, and cancer management guidelines in pregnancy.
Publications Update # 109
Everyones the hero of their own story, management of contralateral groin in vulvar cancer (with video), non-myoinvasive uterine papillary serous carcinoma with positive washings.
Publications Update # 108
An article on insomnia, question of the week (C. Diff testing), fertility preservation outcomes in CAH/G1EC, immunotherapy in transplant patients, and FDA review of PARP inhibitors.
Publications Update # 107
A discussion on how to cure loneliness in the US, Phase 2 trial - Most Circuit - Ipi/Nivo in clear cell cancer, camrelizumab and Famitinb in cervical cancer, impact of prior radiation on immunotherapy drugs, and HRT in young patients.
Publications Update # 106
MAPK/FAK Clamp - RAMP 201 Avutomentinib and Defactinib in Low Grade Ovarian, IP chemotherapy question, ROSELLA Trial and PROFECTA-II Trial, Palliative Oophorectomy in gastric cancers
Publications Update # 105
Making magic with Brad Meltzer, venous thromboembolism during ambulatory chemotherapy in endometrial cancer (including the NCCN and ASCO guidelines), IMRT in vulvar cancer, and hypofractionated adjuvant radiation in cervical cancer patients.
Publications Update # 104
New Episode of GYOEDU Podcast, ASCO abstracts - Challenge trial, TRUST trial, cytoxan+Avastin vs. cytoxan+Avastin+Pembrolizumab, Menopause management with Elinzatenant, and a review of cancer of unknown primary site.
Publications Update # 103
MIS in cervical cancer in SHAPE trial-eligible patients, pragmatic testing with IHC rather to replace the PROMISE algorithm and two questions about PFT and vulvar cancer groin management.